Rapid assay products — Total Revenue
Idexx Laboratories Rapid assay products — Total Revenue increased by 11.7% to $84.94M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.1%, from $84.03M to $84.94M. Over 4 years (FY 2021 to FY 2025), Rapid assay products — Total Revenue shows an upward trend with a 4.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates higher adoption or utilization of in-clinic diagnostic testing by veterinary practices, suggesting strong demand for immediate patient results. A decrease may signal increased competition from reference laboratories or a shift in veterinary diagnostic workflows.
Detailed definition
This metric represents the total revenue generated from the sale of point-of-care diagnostic test kits designed for rapi...
Peer comparison
Comparable to point-of-care diagnostic revenue segments in medical device or life sciences companies, often benchmarked against total diagnostic test kit sales.
idxx_segment_rapid_assay_products_total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $83.89M | $76.97M | $66.38M | $74.52M | $87.48M | $80.54M | $71.13M | $82.03M | $97.34M | $87.56M | $77.56M | $86.32M | $103.29M | $92.77M | $77.38M | $84.03M | $100.24M | $88.64M | $76.04M | $84.94M |
| QoQ Change | — | -8.2% | -13.8% | +12.3% | +17.4% | -7.9% | -11.7% | +15.3% | +18.7% | -10.0% | -11.4% | +11.3% | +19.7% | -10.2% | -16.6% | +8.6% | +19.3% | -11.6% | -14.2% | +11.7% |
| YoY Change | — | — | — | — | +4.3% | +4.6% | +7.1% | +10.1% | +11.3% | +8.7% | +9.0% | +5.2% | +6.1% | +6.0% | -0.2% | -2.6% | -3.0% | -4.5% | -1.7% | +1.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's rapid assay products — total revenue?
- Idexx Laboratories (IDXX) reported rapid assay products — total revenue of $84.94M in Q1 2026.
- How has Idexx Laboratories's rapid assay products — total revenue changed year-over-year?
- Idexx Laboratories's rapid assay products — total revenue increased by 1.1% year-over-year, from $84.03M to $84.94M.
- What is the long-term trend for Idexx Laboratories's rapid assay products — total revenue?
- Over 4 years (2021 to 2025), Idexx Laboratories's rapid assay products — total revenue has grown at a 4.1% compound annual growth rate (CAGR), from $296.85M to $348.95M.
- What does rapid assay products — total revenue mean?
- Total revenue generated from the sale of rapid, in-clinic diagnostic test kits for animals.